BRICS leaders call for stronger cooperation in disease surveillance, medical product regulation
In their New Delhi Declaration, the leaders stressed the importance of strengthening health infrastructure and local production of medical products to enhance preparedness for future health emergencies and ensure timely, affordable and equitable access to healthcare services, vaccines, therapeutics and diagnostics
On September 12, 2026, leaders of the BRICS nations called for enhanced cooperation in disease surveillance and regulation of medical products during their New Delhi Declaration. They welcomed the formation of a dedicated sub-working group to develop an integrated early warning system for preventing and responding to mass infectious diseases.
The declaration emphasized the need for stronger health infrastructure, local production of medical products, and closer collaboration among BRICS medical products regulatory authorities. Recognizing that infectious disease outbreaks, zoonotic threats, antimicrobial resistance, and other public health emergencies know no borders, the leaders stressed the importance of timely information sharing, coordinated action, and resilient surveillance systems to ensure global health security.
The BRICS nations also highlighted the importance of strengthening domestic health infrastructure, local production of medical products, and technical cooperation among public health institutes, all aimed at improving access to healthcare products and services and enhancing collective response capacities for health emergencies.
Written by urgent.news from The Hindu's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
- BRICS leaders call for stronger cooperation in disease surveillance, medical product regulation thehindu.com
- BRICS countries call for stronger cooperation in health, endorse initiatives on TB health.economictimes.indiatimes.com
